We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cell Phone-Enabled Diagnostics Ideal for Developing Countries

By LabMedica International staff writers
Posted on 06 Sep 2012
Emerging countries and remote rural areas that want to quickly establish quality healthcare systems, should consider utilizing cell phone-enabled diagnostics products. More...


The products that are increasingly cell phone-enabled include diabetes smart phones and apps for self-testing and glucose management; cell phones for digital microbiology, hematology, and histology, to send images for consultation; and cell phone-enabled rapid immunoassays focusing on infectious diseases.

There are already 45 companies and foundations that are significantly involved in linking in vitro diagnostics (IVD) products to cellular technology to provide fast results and, sometimes even to provide remote consultations.

Healthcare market research publisher, Kalorama Information (Rockville, MD, USA), in a new report, claimed that the recent trend of cell phone-enabled diagnostics products are arriving just in time for an IVD industry that is looking to earn its fastest revenue growth from emerging nations.

Roche’s (Basel, Switzerland) Accu-Chek Glucose Buddy iPhone app and Arkray’s (Kyoto, Japan) Smart e-SMBG Android app are two examples of cell phone-enabled diagnostics in the glucose field. Tests for sexually transmitted diseases (STDs) and other infectious diseases, which are badly needed for world health, are being developed by universities and companies.

Lack of infrastructure could actually be an advantage for these products in rural areas of the developed world or in the developing world. There is only limited healthcare delivery in rural areas and emerging markets, therefore agencies are ready to utilize the most advanced technologies, which allow point-of-care (POC) devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, to a remote caregiver service for consultation, or to an electronic medical record.

“Approximately 80% of the world’s population lives within range of a cell phone tower,” said Shara Rosen, Kalorama Information’s lead diagnostics analyst. “This means that cell phone technology can bridge the gaps left by a lack of healthcare infrastructure, especially in developing countries. With the aid of a cell phone, health care can be in range for them too.”

Kalorama Information’s report, Cell Phone-Enabled Diagnostics: mHealth Applications in IVD, takes a complete look at the significant companies in the market, gives analyst estimates of the outlook for these types of devices in the IVD market, and analyzes the best areas of IVD for products to succeed.

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices, and healthcare; as well as a full range of custom research services.

Related Links:

Kalorama Information
Roche
Arkray



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.